Enzymecode Biotechnology is a cutting-edge biotech company established in 2017, specializing in the development and production of brain health and nutritional raw materials and food ingredients. Their slogan "Innovative biotechnology advancing brain health and nutritional ingredients" encapsulates their commitment to revolutionizing the biopharma, biotechnology, and nutrition industries.
The company recently secured an Angel Round investment on 29 December 2023 from Draper Dragon, a prominent venture capital firm. This financial backing will likely be instrumental in fortifying Enzymecode's position as a trailblazer in the biotechnology space.
Enzymecode Biotechnology's forward-thinking approach and dedication to advancing brain health and nutritional ingredients make them a compelling investment opportunity in the burgeoning biotech sector.
